• Latest Posts
In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

Cabaletta Bio’s lupus drug cleared for trial

10 immunotherapy companies making waves in 2023

How the microbiome can predict cancer immunotherapy success

Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer

Interview 17 Feb 2023

The benefits – and challenges – of in-house CAR T-cell therapy

ADVERTISEMENT
Sponsored by 7 Feb 2023

Streamlining CAR-T cell therapy manufacturing: a platform approach

Poolbeg expands POLB 001 into oncology

Cartherics granted first patent in China

New biomarker for early prediction of response to CAR-T cell therapy

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

ADVERTISEMENT